Exercise Regimen After Cancer Treatment
This study is looking at how a supervised exercise program, called dose escalated resistance training, affects people who have been treated for cancer. You might be able to join if you are between 20 and 89 years old and are able to do resistance training. The study wants to see if this exercise program can change your body composition, specifically looking at how much fat and muscle you have. Researchers will measure these changes using bioimpedance analysis and ultrasound after 3 months. The study plans to enroll 100 participants, but its current status is unclear.
- Study design
- This is an observational study, meaning researchers will watch and record outcomes from a standard exercise program. It plans to include 100 participants.
- What's involved
- You will engage in resistance training during and/or after your cancer treatment. Your fat and muscle mass will be measured at 3 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Measurements for changes in fat and muscle mass will be taken at 3 months after the regimen.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis3 months
Measurement on bioimpedance analysis machine (Inbody 970)
- Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound3 months
Measurement via ultrasound and calculation with Jackson-Pollack calculations
- Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen3 months
Measurement on bioimpedance analysis machine (Inbody 970)